MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.440
0.00 (0.00%)
At close: May 1, 2026, 4:00 PM EDT
1.430
-0.010 (-0.69%)
After-hours: May 1, 2026, 7:09 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $7.44 million as of May 1, 2026. Its market cap has increased by 0.42% in one year.
Market Cap
7.44M
Enterprise Value
-2.66M
1-Year Change
0.42%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $7.44M, a decrease of -99.99%. That is a compound annual growth rate of -77.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 7.44M | -59.88% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.05M |
| Acurx Pharmaceuticals | 7.93M |
| Enveric Biosciences | 7.92M |
| FibroBiologics | 7.61M |
| Moolec Science | 7.53M |
| Silo Pharma | 7.40M |
| Addex Therapeutics | 7.39M |
| TransCode Therapeutics | 7.18M |